Silk Road Medical (NASDAQ:SILK) PT Raised to $21.00
Silk Road Medical (NASDAQ:SILK – Free Report) had its target price boosted by JPMorgan Chase & Co. from $19.00 to $21.00 in a research note issued to investors on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Other research analysts also recently issued reports about the company. […]